ABSTRACT
PURPOSE: The objective of this study is to evaluate blood glucose (BG) control efficacy and safety of 3 insulin protocols in medical intensive care unit (MICU) patients. METHODS: This was a multicenter randomized controlled trial involving 167 MICU patients with at least one BG measurement >or=150 mg/dL and one or more of the following: mechanical ventilation, systemic inflammatory response syndrome, trauma, or burns. The interventions were computer-assisted insulin protocol (CAIP), with insulin infusion maintaining BG between 100 and 130 mg/dL; Leuven protocol, with insulin maintaining BG between 80 and 110 mg/dL; or conventional treatment-subcutaneous insulin if glucose >150 mg/dL. The main efficacy outcome was the mean of patients' median BG, and the safety outcome was the incidence of hypoglycemia (Subject(s)
Clinical Protocols
, Critical Illness
, Drug Therapy, Computer-Assisted/methods
, Hypoglycemic Agents/administration & dosage
, Insulin/administration & dosage
, Intensive Care Units
, APACHE
, Adult
, Aged
, Blood Glucose/analysis
, Female
, Humans
, Hypoglycemic Agents/therapeutic use
, Infusions, Intravenous
, Injections, Subcutaneous
, Insulin/therapeutic use
, Male
, Middle Aged